Effects of pramipexole on the processing of rewarding and aversive taste stimuli

Psychopharmacology

Volumn 228, Issue 2, 2013, Pages 283-290

  McCabe, Ciara ^a   Harwood, James ^a   Brouwer, Sietske ^a   Harmer, Catherine J ^a   Cowen, Philip J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aversion; Depression; Dopamine agonists; fMRI; Impulse disorders; Parkinson's disease; Reward

Indexed keywords

DOPAMINE AUTORECEPTOR; OXYGEN; PLACEBO; PRAMIPEXOLE;

ADULT; ANTERIOR CINGULATE; ARTICLE; CACAO; CONTROLLED STUDY; CORPUS STRIATUM; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; LEARNING; LOW DRUG DOSE; MALE; MESENCEPHALON; NERVE POTENTIAL; NORMAL HUMAN; ORBITAL CORTEX; OXYGEN BLOOD LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SENSORY STIMULATION; SINGLE DRUG DOSE; STRAWBERRY; TASTE AVERSION; TASTE STIMULUS; THALAMUS;

ADULT; AUTORECEPTORS; AVOIDANCE LEARNING; BENZOTHIAZOLES; BRAIN; DOPAMINE; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REWARD; TASTE; YOUNG ADULT;

EID: 84879977191     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3033-9     Document Type: Article

References (36)

1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
2. Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815-834
3. Campbell-Meiklejohn D, Wakeley J, Herbert V, Cook J, Scollo P, Ray MK, Selvaraj S, Passingham RE, Cowen P, Rogers RD (2011) Serotonin and dopamine play complementary roles in gambling to recover losses. Neuropsychopharmacology 36:402-410
4. Chernoloz O, El Mansari M, Blier P (2009) Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology 34:651-661
5. Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192-205
6. de Araujo IE, Kringelbach ML, Rolls ET, Hobden P (2003a) Representation of umami taste in the human brain. J Neurophysiol 90:313-319
7. de Araujo IE, Kringelbach ML, Rolls ET, McGlone F (2003b) Human cortical responses to water in the mouth, and the effects of thirst. J Neurophysiol 90:1865-1876
8. Dooley M, Markham A (1998) Pramipexole. A review of its use in the management of early and advanced Parkinson's disease. Drugs Aging 12:495-514
9. Dziedzicka-Wasylewska M, Ferrari F, Johnson RD, Mierau J, Rogoz Z, Skuza G, Sokoloff P (2001) Mechanisms of action of pramipexole: effects on receptors. Reviews in Contemporary Pharmacotherapy 12:1-31
10. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders: clinical version. American Psychiatric Press, Washington
11. Friston KJ, Glaser DE, Henson RN, Kiebel S, Phillips C, Ashburner J (2002) Classical and Bayesian inference in neuroimaging: applications. Neuroimage 16:484-512
12. Harmer CJ, Goodwin GM, Cowen PJ (2009) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195:102-108
13. Kallweit U, Khatami R, Pizza F, Mathis J, Bassetti CL (2010) Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. Clin Neuropharmacol 33:276-278
14. Matsumoto M, Hikosaka O (2009) Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459:837-841
15. McCabe C, Rolls ET (2007) Umami: a delicious flavor formed by convergence of taste and olfactory pathways in the human brain. Eur J Neurosci 25:1855-1864
16. McCabe C, Cowen PJ, Harmer CJ (2009) Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) 205:667-677
17. McCabe C, Mishor Z, Cowen PJ, Harmer CJ (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 67:439-445
18. 2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology (Berl) 217:271-278
19. McCabe C, Woffindale C, Harmer CJ, Cowen PJ (2012) Neural processing of reward and punishment in young people at increased familial risk of depression. Biol Psychiatry 72(7):588-594
20. O'Doherty J, Rolls ET, Francis S, Bowtell R, McGlone F (2001) Representation of pleasant and aversive taste in the human brain. J Neurophysiol 85:1315-1321
21. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
22. Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Pajtas PE, Santesso DL, Culhane M (2008) Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) 196:221-232
23. Ray N, Strafella AP (2010) Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging. Clin EEG Neurosci 41:87-93
24. Riba J, Kramer UM, Heldmann M, Richter S, Munte TF (2008) Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One 3:e2479
25. Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6:228-236
26. Rolls ET, Kringelbach ML, de Araujo IE (2003) Different representations of pleasant and unpleasant odours in the human brain. Eur J Neurosci 18:695-703
27. Rolls ET, McCabe C (2007) Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 26:1067-1076
28. Santesso DL, Evins AE, Frank MJ, Schetter EC, Bogdan R, Pizzagalli DA (2009) Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. Hum Brain Mapp 30:1963-1976
29. 3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS & Neurological Disorders Drug Targets 5:25-43
30. van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 34:2758-2766
31. von Zerssen D, Strian F, Schwarz D (1974) Evaluation of depressive states, especially in longitudinal studies. Modern Problems of Pharmacopsychiatry 7:189-202
32. Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M (2011) Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 134:1438-1446
33. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589-595
34. Wilson JL, Jenkinson M, de Araujo I, Kringelbach ML, Rolls ET, Jezzard P (2002) Fast, fully automated global and local magnetic field optimization for fMRI of the human brain. Neuroimage 17:967-976
35. Wise RA (2012) Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry. doi: 10.1016/j.biopsych.2012.09.001
36. Zald DH, Hagen MC, Pardo JV (2002) Neural correlates of tasting concentrated quinine and sugar solutions. J Neurophysiol 87:1068-1075